Evidence map›Paper›PMID 23326516›Full record

ArticlePloS one2013

A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia.

Asma Ben Ammar, Payam Soltanzadeh, Stéphanie Bauché, Pascale Richard, Evelyne Goillot, Ruth Herbst, Karen Gaudon, Caroline Huzé, Laurent Schaeffer, Yuji Yamanashi and 11 more

Erratum issuedOpen access · goldAbstract readCase Reports
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Therapeutic advances of targeting receptor tyrosine kinases in cancer.Signal transduction and targeted therapy · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

21 authors at 9 institutions in 5 countries.

Asma Ben AmmarInserm, UMRS 975, UPMC, Institut du Cerveau et de la Moelle épinière, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Payam Soltanzadeh
Stéphanie Bauché
Pascale Richard
Evelyne Goillot
Ruth Herbst
Karen Gaudon
Caroline Huzé
Laurent Schaeffer
Yuji Yamanashi
Osamu Higuchi
Antoine Taly
Jeanine Koenig
Jean-Paul Leroy
Fayçal Hentati
Hossein Najmabadi
Kimia Kahrizi
Manouchehr Ilkhani
Michel Fardeau
Bruno Eymard
Daniel Hantaï
Inserm · FRSorbonne Université · FRUniversité Claude Bernard Lyon 1 · FRThe University of Tokyo · JPUniversity of Social Welfare and Rehabilitation Sciences · IRCentre National de la Recherche Scientifique · FRMedical University of Vienna · ATNational Institute of Neurology Mongi-Ben Hamida · TNShahid Beheshti University of Medical Sciences · IR

Funding

Austrian Science Fund FWF P 21667
6 · The paper itself

Abstract

Congenital myasthenic syndromes (CMSs) are a heterogeneous group of genetic disorders affecting neuromuscular transmission. The agrin/muscle-specific kinase (MuSK) pathway is critical for proper development and maintenance of the neuromuscular junction (NMJ). We report here an Iranian patient in whom CMS was diagnosed since he presented with congenital and fluctuating bilateral symmetric ptosis, upward gaze palsy and slowly progressive muscle weakness leading to loss of ambulation. Genetic analysis of the patient revealed a homozygous missense mutation c.2503A>G in the coding sequence of MUSK leading to the p.Met835Val substitution. The mutation was inherited from the two parents who were heterozygous according to the notion of consanguinity. Immunocytochemical and electron microscopy studies of biopsied deltoid muscle showed dramatic changes in pre- and post-synaptic elements of the NMJs. These changes induced a process of denervation/reinnervation in native NMJs and the formation, by an adaptive mechanism, of newly formed and ectopic NMJs. Aberrant axonal outgrowth, decreased nerve terminal ramification and nodal axonal sprouting were also noted. In vivo electroporation of the mutated MuSK in a mouse model showed disorganized NMJs and aberrant axonal growth reproducing a phenotype similar to that observed in the patient's biopsy specimen. In vitro experiments showed that the mutation alters agrin-dependent acetylcholine receptor aggregation, causes a constitutive activation of MuSK and a decrease in its agrin- and Dok-7-dependent phosphorylation.

Indexed as

Muscle, SkeletalMuscle WeaknessMyasthenic Syndromes, CongenitalNeuromuscular JunctionAgrinAnimalsChildHEK293 CellsHumansMaleMiceMuscle ProteinsMutation, MissenseReceptor Protein-Tyrosine KinasesReceptors, CholinergicReceptors, Growth FactorAgrinagrin receptorDOK7 protein, humanMuscle ProteinsMUSK protein, humanReceptor Protein-Tyrosine KinasesReceptors, CholinergicReceptors, Growth Factor

Identifiers

PMID23326516
PMCPMC3541344
OpenAlexW2028844634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.